Kreftforeningen
VC Fund
Oslo, Norway
Kreftforeningen is a VC fund in Oslo focused on Biotechnology and Pharmaceutical. The Norwegian Cancer Society (NCS) is one of the largest organisations in Norway representing the voices of those affected by cancer.NCS works continuously to improve society’s attitude to the prevention and treatment of cancer. We fight cancer locally, nationally and globally through research and preventive measures, information, support, adviceand lobbying.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kreftforeningen invests in
Stages Kreftforeningen invests in
Countries Kreftforeningen invests in
Investment Focus
Industry
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
- Clinical Trials 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nykode
|
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops technology for novel vaccines and immunotherapy against HPV-induced malignancies. | $26.3M / Dec 16, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kreftforeningen invest in?
Kreftforeningen invests primarily in Biotechnology, Pharmaceutical and Clinical Trials startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Kreftforeningen last invest?
The most recent investment recorded for Kreftforeningen closed in Dec 2016. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
